301 related articles for article (PubMed ID: 17027524)
1. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
Jacques C; Gosset M; Berenbaum F; Gabay C
Vitam Horm; 2006; 74():371-403. PubMed ID: 17027524
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
3. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
[TBL] [Abstract][Full Text] [Related]
4. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
5. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
6. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators.
Schröder AK; von der Ohe M; Kolling U; Altstaedt J; Uciechowski P; Fleischer D; Dalhoff K; Ju X; Zenke M; Heussen N; Rink L
Immunology; 2006 Nov; 119(3):317-27. PubMed ID: 17067311
[TBL] [Abstract][Full Text] [Related]
7. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.
Abdollahi-Roodsaz S; Joosten LA; Roelofs MF; Radstake TR; Matera G; Popa C; van der Meer JW; Netea MG; van den Berg WB
Arthritis Rheum; 2007 Sep; 56(9):2957-67. PubMed ID: 17763416
[TBL] [Abstract][Full Text] [Related]
10. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins.
Scanu A; Molnarfi N; Brandt KJ; Gruaz L; Dayer JM; Burger D
J Leukoc Biol; 2008 Apr; 83(4):921-7. PubMed ID: 18223103
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
[TBL] [Abstract][Full Text] [Related]
12. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.
Neumann E; Judex M; Kullmann F; Grifka J; Robbins PD; Pap T; Gay RE; Evans CH; Gay S; Schölmerich J; Müller-Ladner U
Gene Ther; 2002 Nov; 9(22):1508-19. PubMed ID: 12407423
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor antagonist gene therapy for arthritis.
Krishnan BR
Curr Opin Mol Ther; 1999 Aug; 1(4):454-7. PubMed ID: 11713759
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
[TBL] [Abstract][Full Text] [Related]
17. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
18. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.
Zhang X; Mao Z; Yu C
J Orthop Res; 2004 Jul; 22(4):742-50. PubMed ID: 15183429
[TBL] [Abstract][Full Text] [Related]
19. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
Lamacchia C; Rodriguez E; Palmer G; Vigne S; Martin P; Talabot-Ayer D; Seemayer CA; Gabay C
Ann Rheum Dis; 2012 Feb; 71(2):281-7. PubMed ID: 22072017
[TBL] [Abstract][Full Text] [Related]
20. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
